DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20172965

Recurrent hydatidiform mole transformed into invasive mole with co-morbid depression- a rare case report

Nisha Bhagat, Rajnish Raj

Abstract


The gestational trophoblastic disease is a group of interrelated lesions that arise from abnormal proliferation of placental trophoblast. It comprises of hydatidiform mole (partial or complete), invasive mole, placental site trophoblastic tumor and choriocarcinoma. The occurrence of hydatidiform mole in more than two conceptions is known as recurrent hydatidiform mole. Although, its incidence is less than 2% but it may progress to invasive mole or choriocarcinoma. The case of 26-year old female is reported; she had five consecutive molar pregnancies and the sixth one developed into invasive mole with co-morbid depression that was managed by methotrexate chemotherapy, antidepressant and psychotherapy.

 


Keywords


Gestational trophoblastic diseases, choriocarcinoma, invasive mole, methotrexate

Full Text:

PDF

References


Helwani MN, Seoud M, Zahed L, Zaatari G, Khalil A, Slim R. A familial case of recurrent hydatidiform molar pregnancies with biparental genomic contribution. Hum Genet. 1999;105:112-5.

Palmer JR. Advances in the epidemiology of gestational trophoblastic disease. J Reprod Med. 1994;39:155-62.

Bagshawe KD, Dent J, Webb J. Hydatidiform mole in England and Wales. Lancet. 1986; 2:673-7.

Smith DB, O’Rcilly SM, Newlands ES. Current approaches to diagnosis and treatment of gestational trophoblastic disease J Ultrasound Med. 1993;12:59-62.

Hammond CB. Gestational trophoblastic neoplasms. In: Scott JR, DiSaia PJ, Spellacy WN, eds. Danforth’s Obstetrics and Gynecology. 8th ed. Philadelphia:Lippincott Williams and Wilkins;1999:927-37.

American Psychiatric Association. Diagnostic and Statistical manual of mental disorders (DSM-5). 5th ed. Arlington, VA: American Psychiat Assoc, Washington DC;2013.

Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134(4):382-9.

McGahuey CA, Gelenberg AJ, Laukes CA, Moreno FA, Delgado PL, McKnight KM, et al. The Arizona Sexual Experience Scale (ASEX): reliability and validity. J Sex and Marital Therapy. 2000;26:1.

Beneke M, Rasmus W. Clinical global impressions (ECDEU): some critical comments. Pharmacopsychiat. 1992;25:171-6.

Levitas E, Lunenfeld E, Weisz N, Friger M, Potashnik G. Relationship between age and semen parameters in men with normal sperm concentration: Analysis of 6022 semen samples. Andrologia. 2007;39:45-50.

Palmer JR, Driscoll SG, Rosenberg L, Berkowitz RS, Lurain JR, Soper J, et al. Oral contraceptive use and risk of gestational trophoblastic tumors. J Nat Cancer Inst. 1999;91:635-40.

Fisher RA. Genetics. In: Hancock BW, Newlands ES, Berkowitz RS, eds. Gestational Trophoblastic Disease. London, UK:Chapman and Hall;1997:5-26.

Steigrad SJ. Epidemiology of gestational trophoblastic diseases. Best Pract Res Clin Obstet Gynecol. 2003;17:837-47.

Sebire NJ, Foskett RA, Fisher RA, Rees H, Seckl M, Newlands E. Risk of partial and complete hydatidiform molar pregnancy in relationship to maternal age. Br J Obstet Gynecol. 2002;109:99-102.

Moglabey YB, Kircheisen R, Seoud M, El Mogharbel N, Van den Veyver I, Slim R. Genetic mapping of a maternal locus responsible for familial hydatidiform moles. Hum Mol Genet. 1999;8:667-71.

Kohorn EI, Goldstein DP, Hancock BW, Kim SJ, Lurain JR, Newlands E et al. Combining the staging system of the International Federation of Gynecology and Obstetrics with the scoring system of the World Health Organization for trophoblastic neoplasia. Report of the Working Committee of the International Society for the Study of Trophoblastic Disease and the International Gynecologic Cancer Society. Int J Gynecol Cancer. 2000;10:84-8.

Homesley HD. Single agent therapy for non-metastatic and low risk gestational trophoblastic disease. J Reprod Med. 1998;43:69-73.

Ramirez AJ, Watson JP, Richards MA, Fentiman IS, Gregory WM, Rubens RD, et al. Life events and breast cancer prognosis. BMJ: British Medical Journal. 1992;304(6842):1632.

McDaniel JS, Musselman DL, Porter MR, Reed DA, Nemeroff CB, et al. Depression in patients with cancer: diagnosis, biology and treatment. Arch Gen Psychiatry. 1995;52:89-99.

Graham J, Ramirez A, Love S, Richards M and Burgess C. Stressful life experiences and risk of relapse of breast cancer: observational cohort study. BMJ: Br Med J. 2002;324(7351):1420.